RayThera is a small molecule drug discovery company with a mission to develop safer, more effective therapeutics to treat patients with immunological diseases. Co-founded by Qing Dong, Ph.D., and Gene Hung, M.D., the company is led by a team of highly skilled drug hunters and executives with an extraordinary track record in the biotech and pharma industries.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/04/25 | $110,000,000 | Series A |
Foresite Capital OrbiMed Advisors TTM Capital | undisclosed |
